Literature DB >> 4850789

Biotransformation of isosorbide dinitrate in humans.

W H Down, L F Chasseaud, R K Grundy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4850789     DOI: 10.1002/jps.2600630728

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  15 in total

1.  Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate.

Authors:  F Wagner; F Siefert; D Trenk; E Jähnchen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.

Authors:  G Müller; W Häcker; B Schneider
Journal:  Klin Wochenschr       Date:  1983-04-15

3.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

4.  Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.

Authors:  L F Chasseaud; W H Down; R K Grundy
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

5.  Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosage.

Authors:  J Evers; R Bonn; A Boertz; W Cawello; H A Dickmans; M Weiss
Journal:  Klin Wochenschr       Date:  1989-03-15

Review 6.  Clinical pharmacokinetics of organic nitrates.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

7.  Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.

Authors:  W Schneider; G Menke; R Heidemann; P Satter; M Kaltenbach; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Pharmacokinetics of stereomeric 1,4:3,6-dianhydrohexitol mononitrates in rats.

Authors:  T B Tzeng; H L Fung
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

9.  Fate of isosorbide dinitrate and mononitrates in patients with renal failure.

Authors:  M G Bogaert; M T Rosseel; J Boelaert; R Daneels
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate.

Authors:  I W Taylor; R M Major; L F Chasseaud; T Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.